BioCentury
ARTICLE | Company News

EpiTherapeutics, ExpreS2ion, Nuevolution, University of Copenhagen deal

October 18, 2010 7:00 AM UTC

The parties formed a JV focused on developing drugs to treat epigenetic disorders. Nuevolution will use its Chemetics drug discovery technology to screen small molecules. EpiTherapeutics, which is par...